OverviewSuggest Edit

Immunodiagnostic Systems (IDS) is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. The Company's development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Its IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing. IDS has its global headquarters in the UK, and has subsidiaries in the USA, Germany, France, and Denmark. Other markets, including key diagnostic markets of Spain, Italy, Australia, and Japan, are serviced by a network of highly qualified and experienced distributors within each territory.

TypePublic
Founded1977
HQBoldon Colliery, GB
Websiteidsplc.com

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)286(+2%)
Job Openings6
Revenue (FY, 2019)£38.5 M(+2%)
Share Price (Oct 2017)£2.9

Key People/Management at Immunodiagnostic Systems

Regis Duval

Regis Duval

CEO

Immunodiagnostic Systems Office Locations

Immunodiagnostic Systems has offices in Boldon Colliery, Gaithersburg, Scottsdale, East Brisbane and in 29 other locations
Boldon Colliery, GB (HQ)
10 Didcot Way
East Brisbane, AU
12 Mowbray Terrace
Liège, BE
Rue Ernest Solvay 101
Markham, CA
50 Valleywood Dr
Kralupy nad Vltavou, CZ
Vodárenská
København, DK
Center Blvd. 5
Show all (45)

Immunodiagnostic Systems Financials and Metrics

Immunodiagnostic Systems Revenue

Embed Graph
View revenue for all periods
Immunodiagnostic Systems's revenue was reported to be £38.51 m in FY, 2019
GBP

Revenue (FY, 2019)

38.5m

Gross profit (FY, 2019)

16.7m

Gross profit margin (FY, 2019), %

43.4%

Net income (FY, 2019)

796.0k

EBITDA (FY, 2019)

4.9m

EBIT (FY, 2019)

429.0k

Market capitalization (31-Oct-2017)

84.6m

Closing stock price (31-Oct-2017)

2.9

Cash (31-Mar-2019)

27.7m
Immunodiagnostic Systems's current market capitalization is £84.6 m.
GBPFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

38.3m40.0m37.9m38.5m

Revenue growth, %

(16%)5%(5%)

Cost of goods sold

15.8m20.1m19.9m21.8m

Gross profit

22.5m19.9m18.0m16.7m
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

446.7k885.1k959.8k3.0m4.5m5.3m6.4m11.0m19.6m26.7m23.7m26.6m31.5m28.5m27.7m

Accounts Receivable

922.8k1.3m1.6m4.0m4.4m6.4m7.8m3.6m7.3m5.2m5.4m5.3m6.6m7.4m

Inventories

762.6k805.2k914.6k6.2m5.7m6.4m8.5m7.5m5.9m6.5m6.8m7.5m7.6m8.4m7.8m

Current Assets

2.5m3.3m4.0m14.0m19.4m23.2m27.8m27.4m35.9m42.5m40.7m43.2m48.9m48.4m47.5m
GBPFY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

212.3k916.9k1.6m2.8m4.2m8.1m12.9m4.7m7.8m7.0m2.4m(32.2m)3.0m1.2m796.0k

Cash From Operating Activities

248.2k1.2m2.1m445.0k5.3m9.7m16.5m14.3m18.4m12.3m8.8m8.2m8.4m2.5m5.8m

Dividends Paid

133.4k202.0k360.3k436.3k559.0k708.0k215.0k866.0k2.5m876.0k353.0k1.2m500.0k

Cash From Financing Activities

1.5m(286.7k)(688.7k)24.9m1.9m(1.9m)(5.5m)(2.1m)(5.0m)854.0k(2.6m)(985.0k)(537.0k)(1.4m)(2.0m)
GBPY, 2019

Revenue/Employee

135.8k

Financial Leverage

1.2 x
Show all financial metrics

Immunodiagnostic Systems Online and Social Media Presence

Embed Graph

Immunodiagnostic Systems Blogs

Join IDS at MEDICA 2019

MEDICA is the world’s largest event for the medical sector, hosting over 5,100 exhibitors, from 70 different countries. In-patient and out-patient medicine, medical technology, diagnostic systems and electromedical and laboratory equipment are all on display throughout the event. The exhibition welc…

Join IDS at MEDLAB Dubai 2019

MEDLAB is an important event in the international medical laboratory community calendar. The gathering will welcome hundreds of exhibitors and will be accompanied by 11 CME-accredited conferences. This year, the congress will be led by a strong scientific committee, focusing upon current issues and …

CEO Discusses the Value Created by IDS

“We are a specialist in-vitro diagnostic solution provider to the clinical laboratory market,” begins Jaap Stuut, the Group CEO of Immunodiagnostic Systems (IDS). His firm and proud statement is equally substantiated by the value that the company has created over the years. IDS has not only manufact…

Immunodiagnostic Systems Frequently Asked Questions

  • When was Immunodiagnostic Systems founded?

    Immunodiagnostic Systems was founded in 1977.

  • Who are Immunodiagnostic Systems key executives?

    Immunodiagnostic Systems's key executives are Regis Duval.

  • How many employees does Immunodiagnostic Systems have?

    Immunodiagnostic Systems has 286 employees.

  • What is Immunodiagnostic Systems revenue?

    Latest Immunodiagnostic Systems annual revenue is £38.5 m.

  • What is Immunodiagnostic Systems revenue per employee?

    Latest Immunodiagnostic Systems revenue per employee is £134.7 k.

  • Who are Immunodiagnostic Systems competitors?

    Competitors of Immunodiagnostic Systems include Great Basin Scientific, Abaxis and PTS Diagnostics.

  • Where is Immunodiagnostic Systems headquarters?

    Immunodiagnostic Systems headquarters is located at 10 Didcot Way, Boldon Colliery.

  • Where are Immunodiagnostic Systems offices?

    Immunodiagnostic Systems has offices in Boldon Colliery, Gaithersburg, Scottsdale, East Brisbane and in 29 other locations.

  • How many offices does Immunodiagnostic Systems have?

    Immunodiagnostic Systems has 45 offices.